<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND &amp; OBJECTIVES: DNA mismatch repair gene (MMR) abnormalities are seen in 95 per cent of <z:e sem="disease" ids="C1333990" disease_type="Neoplastic Process" abbrv="">hereditary nonpolyposis colorectal cancer</z:e> (HNPCC) and 10-15 per cent of <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>There are no data on MMR abnormalities in Malaysian <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
<SENT sid="2" pm="."><plain>This study was aimed to determine the frequency of <z:mp ids='MP_0009797'>abnormal MMR</z:mp> gene protein expression in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> in Northern Peninsular Malaysia using immunohistochemistry </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Clinicopathological information was obtained from 148 patients' records who underwent bowel resection for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) at the three hospitals in Malaysia </plain></SENT>
<SENT sid="4" pm="."><plain>Immunohistochemistry for MLH1, MSH2, MSH6 and PMS2 proteins were performed on paraffin embedded tissue containing <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: A total of 148 subjects and 150 colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> of <z:hpo ids='HP_0003745'>sporadic</z:hpo> and hereditary types were assessed </plain></SENT>
<SENT sid="6" pm="."><plain>Three patients had synchronous <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Twenty eight <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (18.6%) from 26 subjects (17.6%) had absent immunohistochemical expression of any one of the MMR gene proteins </plain></SENT>
<SENT sid="8" pm="."><plain>This comprised absent MLH1 only - 3 cancers, absent MSH2 only - 3, absent MSH6 only - 2, absent PMS2 only - 3, absent MLH1 and PMS2 - 14, absent MSH2 and MSH6 - 2 and absent MLH1, MSH6 and PMS2 - 1 </plain></SENT>
<SENT sid="9" pm="."><plain>There was significant association between <z:mp ids='MP_0009797'>abnormal MMR</z:mp> gene protein expression and proximal <z:hpo ids='HP_0003003'>colon cancers</z:hpo>, mucinous, signet ring and poorly differentiated <z:mp ids='MP_0000002'>morphology</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>INTERPRETATION &amp; CONCLUSIONS: <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancers</z:e> with <z:mp ids='MP_0009797'>abnormal MMR</z:mp> gene expression were associated with microsatellite instability-high (MSI-H) phenotype </plain></SENT>
<SENT sid="11" pm="."><plain>About 15 per cent demonstrated absent MSH2, MSH6 and PMS2 protein expression in isolation or in combination with other MMR genes, which often predicts a germline mutation, synonymous with a diagnosis of HNPCC </plain></SENT>
<SENT sid="12" pm="."><plain>This appears to be high frequency compared to reported data </plain></SENT>
</text></document>